← All stories
Health, Longevity & Biohacking

NMR ‘glyc’ inflammation marker described as more stable than CRP

By Egleze Editorial Desk · Published August 3, 2026 · Peter Attia Drive · 402 ‒ NMR blood analysis: how mortality risk and more can be assessed from a single blood sample
NMR ‘glyc’ inflammation marker described as more stable than CRP
Peter Attia Drive
Peter Attia Drive
402 ‒ NMR blood analysis: how mortality risk and more can be assessed from a single blood sample

What was said

""it's a very stable parameter because it's the integration of lots of different things. So rather than CRP that you typically measure clinically to assess inflammation, it's very volatile.""

Otvos explains that an NMR signal known as “glyc” reflects glycan components on multiple acute-phase proteins and is correlated with inflammatory markers such as IL‑6. He argues it is less day-to-day variable than high-sensitivity CRP and can add independent predictive value in risk models.

Verification status

Attributed speaker claim

Egleze verified who said this and where. The underlying claim has not been independently established by Egleze.

Source and context

Egleze verified who said this and where. The underlying claim has not been independently established by Egleze.

Programme
Peter Attia Drive
Episode
402 ‒ NMR blood analysis: how mortality risk and more can be assessed from a single blood sample
Clip time
1:30:06
Original source
Watch the source segment →
From this episode
Peter Attia Drive
Peter Attia Drive

402 ‒ NMR blood analysis: how mortality risk and more can be assessed from a single blood sample

August 3, 2026 · 2h 27m · 7 Egleze moments
Read episode summary and key points →

More moments from this episode

Health, Longevity & BiohackingOtvos says MVX mortality-risk score is ‘virtually unassociated’ with age→Health, Longevity & BiohackingOtvos says ‘fluffy’ LDL does not offset risk when LDL particle count is high→AI & TechOtvos says NMR plus machine learning can output ApoB and lipid panel cheaply→Health, Longevity & BiohackingOtvos says unpublished Diabetes Prevention Program analysis found LPIR outperformed insulin→
More stories More from Peter Attia Drive